NDC 42291-779

Rasagiline

Rasagiline

Rasagiline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Rasagiline Mesylate.

Product ID42291-779_c2c89165-301e-54d0-e053-2995a90a7d4a
NDC42291-779
Product TypeHuman Prescription Drug
Proprietary NameRasagiline
Generic NameRasagiline
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-05-20
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA021641
Labeler NameAvKARE
Substance NameRASAGILINE MESYLATE
Active Ingredient Strength1 mg/1
Pharm ClassesMonoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 42291-779-30

30 TABLET in 1 BOTTLE (42291-779-30)
Marketing Start Date2021-05-20
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Rasagiline" or generic name "Rasagiline"

NDCBrand NameGeneric Name
0093-3060RasagilineRasagiline
0093-3061RasagilineRasagiline
16714-770RasagilineRasagiline
16714-771RasagilineRasagiline
42291-779RasagilineRasagiline
42291-780RasagilineRasagiline
42571-220RASAGILINERasagiline
42571-221RASAGILINERasagiline
47781-683RasagilineRasagiline
47781-690RasagilineRasagiline
67877-259RasagilineRasagiline
67877-260RasagilineRasagiline

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.